公开(公告)号：US20180238919A1

公开(公告)日：2018-08-23

申请号：US15961182

申请日：2018-04-24

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/00 ,  G01N35/10 ,  G01N35/02 ,  G01N33/86

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US09810705B2

公开(公告)日：2017-11-07

申请号：US15249565

申请日：2016-08-29

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/02 ,  G01N35/10 ,  G01N35/00 ,  G01N33/86

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US20160370391A1

公开(公告)日：2016-12-22

申请号：US15249565

申请日：2016-08-29

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/00 ,  G01N35/10 ,  G01N35/02 ,  G01N33/86

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method comprises adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid comprises parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid comprises parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US20150362516A1

公开(公告)日：2015-12-17

申请号：US14732132

申请日：2015-06-05

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/10 ,  G01N33/86 ,  G01N35/02

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method comprises adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid comprises parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid comprises parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

Abstract translation: 描述了用于自动体外诊断分析的方法和系统。 该方法包括在第一和第二循环时间期间将第一试剂类型和第二试剂类型添加到第一测试液体。 向第一测试液体添加第一试剂类型包括在第一循环时间期间向第二测试液体平行添加第二试剂类型。 向第一测试液体添加第二试剂类型包括分别在第二循环时间期间向第三测试液体平行添加第一试剂类型。

公开(公告)号：US10684297B2

公开(公告)日：2020-06-16

申请号：US16274581

申请日：2019-02-13

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N33/86 ,  G01N35/00 ,  G01N35/02 ,  G01N35/10

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US10247744B2

公开(公告)日：2019-04-02

申请号：US15961182

申请日：2018-04-24

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/02 ,  G01N35/10 ,  G01N35/00 ,  G01N33/86

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US20160370392A1

公开(公告)日：2016-12-22

申请号：US15249599

申请日：2016-08-29

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/00

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method comprises adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid comprises parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid comprises parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US20190178902A1

公开(公告)日：2019-06-13

申请号：US16274581

申请日：2019-02-13

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/00 ,  G01N35/10 ,  G01N33/86 ,  G01N35/02

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US09983221B2

公开(公告)日：2018-05-29

申请号：US15249599

申请日：2016-08-29

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/02 ,  G01N35/10 ,  G01N35/00 ,  G01N33/86

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

公开(公告)号：US09459270B2

公开(公告)日：2016-10-04

申请号：US14732132

申请日：2015-06-05

Applicant: Roche Diagnostics Operations, Inc.

Inventor： Thomas Meyer ,  Gottlieb Schacher ,  Rolf Sigrist ,  Christian Guzek

IPC: G01N35/02 ,  G01N35/10 ,  G01N35/00

CPC classification number: G01N35/0092 ,  G01N33/86 ,  G01N35/026 ,  G01N35/1002 ,  G01N35/1065 ,  G01N2035/00356 ,  G01N2035/00524 ,  G01N2035/0094 ,  Y10T436/113332 ,  Y10T436/114165 ,  Y10T436/115831 ,  Y10T436/2575

Abstract: A method and system for automatic in-vitro diagnostic analysis are described. The method includes adding a first reagent type and a second reagent type to a first test liquid during a first and second cycle times respectively. The addition of the first reagent type to the first test liquid includes parallel addition of a second reagent type to a second test liquid during the first cycle time. The addition of the second reagent type to the first test liquid includes parallel addition of a first reagent type to a third test liquid during the second cycle time, respectively.

Abstract translation: 描述了用于自动体外诊断分析的方法和系统。 该方法包括在第一和第二循环时间期间将第一试剂类型和第二试剂类型添加到第一测试液体。 将第一试剂类型添加到第一测试液体包括在第一循环时间期间将第二试剂类型平行添加到第二测试液体。 向第一测试液体添加第二试剂类型包括分别在第二循环时间期间向第三测试液体平行添加第一试剂类型。